Economic evaluation of docetaxel-gemcitabine versus vinorelbine-cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis (Q43216779)
Jump to navigation
Jump to search
scientific article published on 17 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Economic evaluation of docetaxel-gemcitabine versus vinorelbine-cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis |
scientific article published on 17 December 2009 |
Statements
1 reference
Economic evaluation of docetaxel-gemcitabine versus vinorelbine-cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis (English)
1 reference
N Maniadakis
1 reference
V Fragoulakis
1 reference
A G Pallis
1 reference
E Simou
1 reference
V Georgoulias
1 reference
17 December 2009
1 reference
1 reference
21
1 reference
7
1 reference
1462-1467
1 reference
Identifiers
1 reference
1 reference